DMEK

Latest news

Tag

Determinants of Endothelial Cell Density One Year After DMEK: Insights from the Diabetes Endothelial Keratoplasty Study

This analysis from the DEKS trial identifies donor endothelial damage, recipient diagnosis, and intraoperative complications as key factors influencing endothelial cell density at one year post-DMEK, highlighting the importance of donor tis

Aug 4, 2026Sign in to read

Diabetes & Endocrinology

Determinants of One-Year Success in Descemet Membrane Endothelial Keratoplasty: Insights from the Diabetes Endothelial Keratoplasty Study

This article examines factors influencing the one-year success rate of DMEK in treating corneal endothelial dysfunction, highlighting the impact of operative complications and donor-recipient variables based on findings from the Diabetes En

Aug 2, 2026Sign in to read

Diabetes & Endocrinology

Donor Diabetes Status Does Not Compromise DMEK Outcomes: 1-Year Results from the DEKS Randomized Clinical Trial

The Diabetes Endothelial Keratoplasty Study (DEKS) confirms that donor diabetes status has no clinically significant impact on 1-year graft success rates or endothelial cell loss after Descemet membrane endothelial keratoplasty (DMEK), faci

Jan 10, 2026